Nanalysis Scientific Corp.
NSCIF
$0.1858
$0.00040.22%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -15.92% | 13.28% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -15.92% | 13.28% | |||
| Cost of Revenue | -5.18% | 4.21% | |||
| Gross Profit | -36.70% | 36.24% | |||
| SG&A Expenses | 1.91% | -7.17% | |||
| Depreciation & Amortization | -22.85% | -3.63% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.87% | 0.54% | |||
| Operating Income | -410.11% | 132.16% | |||
| Income Before Tax | 83.65% | -344.05% | |||
| Income Tax Expenses | 291.19% | -977.27% | |||
| Earnings from Continuing Operations | 82.89% | -341.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 82.89% | -341.64% | |||
| EBIT | -410.11% | 132.16% | |||
| EBITDA | -247.62% | 176.25% | |||
| EPS Basic | 83.01% | -340.19% | |||
| Normalized Basic EPS | -84.62% | 60.00% | |||
| EPS Diluted | 83.01% | -220.41% | |||
| Normalized Diluted EPS | -84.62% | 60.00% | |||
| Average Basic Shares Outstanding | 0.08% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.08% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||